DTL
IOVA icon

Dynamic Technology Lab’s Iovance Biotherapeutics IOVA Stock Holding History

Dynamic Technology Lab’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,872
Closed -$46K – 1016
2025
Q4 		$46K Buy
+16,872
New +$39K 0.01% 696
2025
Q1 		– Sell
-17,945
Closed -$133K – 1176
2024
Q4 		$133K Buy
+17,945
New +$166K 0.02% 808
2023
Q4 		– Sell
-26,791
Closed -$122K – 1208
2023
Q3 		$122K Sell
26,791
-86,538
-76% -$565K 0.01% 847
2023
Q2 		$798K Buy
113,329
+55,881
+97% +$400K 0.1% 339
2023
Q1 		$351K Buy
+57,448
New +$396K 0.03% 744
2022
Q4 		– Sell
-43,907
Closed -$421K – 1299
2022
Q3 		$421K Buy
43,907
+30,464
+227% +$351K 0.04% 694
2022
Q2 		$148K Buy
+13,443
New +$176K 0.02% 950
2022
Q1 		– Sell
-20,744
Closed -$396K – 1284
2021
Q4 		$396K Buy
20,744
+12,254
+144% +$270K 0.04% 695
2021
Q3 		$209K Buy
+8,490
New +$200K 0.03% 898
2021
Q2 		– Sell
-16,388
Closed -$519K – 1311
2021
Q1 		$519K Buy
+16,388
New +$679K 0.06% 549
2020
Q3 		– Sell
-13,051
Closed -$358K – 1159
2020
Q2 		$358K Buy
+13,051
New +$429K 0.05% 602
2020
Q1 		– Sell
-8,409
Closed -$233K – 1198
2019
Q4 		$233K Buy
+8,409
New +$191K 0.04% 778
2019
Q2 		– Sell
-29,085
Closed -$277K – 1122
2019
Q1 		$277K Buy
+29,085
New +$283K 0.05% 710
2018
Q4 		– Sell
-25,033
Closed -$282K – 1125
2018
Q3 		$282K Buy
+25,033
New +$355K 0.04% 770
2017
Q4 		– Sell
-17,143
Closed -$133K – 1155
2017
Q3 		$133K Buy
+17,143
New +$108K 0.02% 952
2016
Q4 		– Sell
-11,088
Closed -$91K – 1011
2016
Q3 		$91K Buy
+11,088
New +$93.8K 0.02% 822

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Dynamic Technology Lab's IOVA Position: Q1 2026 in Review

Dynamic Technology Lab sold out of Iovance Biotherapeutics (IOVA) in Q1 2026, closing a stake of 16,872 shares — an estimated $46K sold.

Dynamic Technology Lab first reported a position in IOVA in Q3 2016 and held it in 16 quarters. The position peaked at $798K in Q2 2023. 286 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Dynamic Technology Lab reported no remaining Iovance Biotherapeutics position as of Q1 2026 after selling out during the quarter.
  • Dynamic Technology Lab sold 16,872 Iovance Biotherapeutics shares in Q1 2026, an estimated $46K.
  • Dynamic Technology Lab first reported a position in Iovance Biotherapeutics in Q3 2016 and held it in 16 quarters.
  • Dynamic Technology Lab's Iovance Biotherapeutics position peaked at $798K in Q2 2023.
  • 286 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Dynamic Technology Lab's 13F filing for Q1 2026, filed 15 May 2026.